🏛️ Verified NIH Record • Updated 2026-08-04

Vercise™ DBS Dystonia Prospective Study (NCT02686125)

Prospective Study of Deep Brain Stimulation With the VERCISE™ System for Treatment of Dystonia

🟢 Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: Boston Scientific Corporation

🩺 Plain-English Summary (8th-Grade Level)

To compile characteristics of real-world outcomes of Boston Scientific Corporation's commercially approved VerciseTM Deep Brain Stimulation (DBS) Systems for the treatment of dystonia.

Who can join: To join this study, participants generally need to meet the listed inclusion criteria (3 items) and avoid the listed exclusions (2 items).

Location: AZ Sint-Lucas — Ghent

Age range: 7 Years

🧪 Interventions in This Study

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Check every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).

Usually NOT eligible if any of the following apply:

  • Exclusion Criteria (EC):
  • EC1. Meets any contraindication in the Vercise System locally applicable Directions for Use.

🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.

📍 All Participating Trial Locations (36 Sites)

Showing the first 25 of 36 sites.

  • AZ Sint-Lucas — Ghent,
  • UZ Gasthuisberg — Leuven,
  • Queen Elizabeth II Health Sciences Center — Halifax,
  • University Berlin, Charite Virchow Standort, Wedding — Berlin,
  • Uniklinik Köln — Cologne,
  • Universitaetsklinikum Dusseldorf — Düsseldorf,
  • Universitaetsklinikum Freiburg — Freiburg im Breisgau,
  • Universitaetsklinik Eppendorf — Hamburg,
  • St. Barbara-Klinik Hamm-Heessen — Hamm,
  • Medizinische Hochschule Hannover MHH — Hanover,
  • Universitatsklinikum Campus Kiel — Kiel,
  • Johannes Gutenberg Universitaet Mainz — Mainz,
  • Universitaetsklinikum Giessen und Marburg GmbH — Marburg,
  • Evangelisches Krankenhaus Oldenburg — Oldenburg,
  • Universitaetsklinikum Wuerzburg — Würzburg,
  • Medical School of University PECS — Pécs,
  • Hadassah Hebrew University Medical Center — Jerusalem,
  • Azienda Ospedaliero-Universitaria di Ferrara — Ferrara,
  • Ospedale Dell Angelo — Mestre,
  • Policlinico Universitario Agostino Gemelli — Rome,
  • Osp. S. Maria Della Misericordia — Udine,
  • Haga Ziekenhuis locatie Leyweg — The Hague,
  • 10 Military Clinical Hospital Bydgoszcz — Bydgoszcz,
  • Wojewodzki Szpital Dzieciecy Jozefa Brudzinskiego (Childrens Hospital Bydgoszcz) — Bydgoszcz,
  • Podmiot Leczniczy Copernicus Sp. z o.o. — Gdansk,

📞 Contact the Study Coordinator

Phone: (855) 213-9890

Email: BSNClinicalTrials@bsci.com

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

Explore by condition: All Dystonia clinical trials

💡 How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Contact the study coordinator using the phone/email above.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
🏛️ View Official NIH Record ↗